Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06639334

The Q-REDUCE Study

A Quick Pathway for Patients With High pRobability of dislocatEd Hemi- or Total Hip Arthroplasty to Minimize the Time From Hospital aDmission to redUCtion of the prosthEsis

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
University of Southern Denmark · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to design a fast-track pathway for patients referred to the University Hospital of Southern Denmark, Esbjerg, with high probability of having a dislocated hip prosthesis with the primary aim to reduce the time from arrival to reduction and the total hospitalization time. Secondary aims are to * investigate whether quicker prosthesis reduction influences on hip function and quality of life afterwards * reduce the pain experience immediately and in the long term * increase patient satisfaction without changing the overall complication rate and readmission/mortality

Conditions

Interventions

TypeNameDescription
OTHERFasttrack pathway for THA/HE prosthesis reductionThe purpose of this study is to design a fast-track pathway for patients referred to the University Hospital of Southern Denmark, Esbjerg, with high probability of having a dislocated hip prosthesis with the primary aim to reduce the time from arrival to reduction and the total hospitalization time. The intervention is changed logistic and work pathways at the hospital that should reduce time to reduction significantly. For detailed description we refer to the uploaded protocol.
OTHERStandard pathway for THA/HE prosthesis reductionStandard treatment for a dislocated THA/HA at our institution is education in general anesthesia at the operating theater. For detailed description we refer to the uploaded protocol.

Timeline

Start date
2024-11-01
Primary completion
2026-08-31
Completion
2027-08-31
First posted
2024-10-15
Last updated
2024-10-15

Source: ClinicalTrials.gov record NCT06639334. Inclusion in this directory is not an endorsement.